The change rate is high and the direction is one-way. For a cancer diagnosis, a surgery, or a long-term drug, a second opinion revises the diagnosis or the plan in roughly a quarter to half of cases 1. Reviewing outside breast-cancer cases, surgery recommendations changed for 52% 2. Across four cancers at Sloan Kettering the second look was almost twice as likely to remove something as to add it: 21 planned surgeries cancelled, 9 patients moved to watchful waiting 3. The disease usually survives the second look; the plan often does not.
Volume is why. A general pathologist might read four soft-tissue tumours a year; a subspecialist reads four hundred. Re-reading 2,718 outside pathology cases, MD Anderson disagreed 25% of the time, 6% of it treatment-changing 4. The second clinician also starts fresh, free of the first one's working guess. Diagnostic error is common enough that most people hit at least one in a lifetime 5.
Four steps, in order.
Insurance covers it: Medicare Part B pays 80% as for a first visit, most commercial plans match, and an uninsured virtual consult runs $40 to $500. Downstream, changed plans saved about $15,000 per patient, mostly from cancelled surgeries and drug courses 6.
What you get. Within one to two weeks you have an answer: a treatment that fits the actual disease, or confidence in the one you had. Six months out, people who got a second opinion report far less decision regret regardless of how treatment went, because the question they were carrying is already answered 1. In the cases where it pulled an unneeded surgery off the table, the payoff is a year of your life you keep.
The fine print — when to skip it, and what people get wrong
Myths. The doctor who would be offended is the one whose read you most want checked. It is not just a cancer thing: the 12% Mayo number is from general internal medicine, not oncology 7.
Where it goes wrong. Doctor-shopping: a third and fourth opinion chasing a preferred answer just delays treatment. Asking a fellow generalist instead of a subspecialist. Skipping the records, so the second doctor only reproduces the first read.
When to skip the wait. Inflammatory breast cancer, acute leukaemia, suspected stroke, heart attack, or sepsis: start treatment immediately and get the second opinion in parallel, not before.
- 1Payne VL, Singh H, Meyer AND, Levy L, Harrison D, Graber ML (2014). Patient-initiated second opinions: systematic review of characteristics and impact on diagnosis, treatment, and satisfaction. Mayo Clinic Proceedings. link
- 2Newman EA, Guest AB, Helvie MA, et al. (2006). Changes in surgical management resulting from case review at a breast cancer multidisciplinary tumor board. Cancer. link
- 3Lipitz-Snyderman A, Kennedy AJ, Foote M, et al. (2023). Clinical value of second opinions in oncology: a retrospective review of changes in diagnosis and treatment recommendations. Cancer Medicine. link
- 4Middleton LP, Feeley TW, Albright HW, Walters R, Hamilton SH (2014). Second-opinion pathologic review is a patient safety mechanism that helps reduce error and decrease waste. Journal of Oncology Practice. link
- 5National Academies of Sciences, Engineering, and Medicine (2015). Improving Diagnosis in Health Care. link
- 6Roman BR, Lipitz-Snyderman A, et al. (2025). What is the cost impact of second opinions in oncology? A retrospective review. JCO Oncology Practice. link
- 7Van Such M, Lohr R, Beckman T, Naessens JM (2017). Extent of diagnostic agreement among medical referrals. Journal of Evaluation in Clinical Practice. link
დაკავშირებული სახელმძღვანელოში (6)
- — Knowing who decides matters as much as what's decided. Name a healthcare proxy before a crisis takes the choice out of your hands.
- — Autoimmune disease in women is exactly where a second opinion can break years of being dismissed.
- — An alarming MRI report is a classic trigger to get another set of eyes before agreeing to surgery.
- — When you seek a second opinion, the NNT is the number to ask for — how many people benefit, not just the relative-risk headline.
- — A personal record of your scans and results is what makes getting a second opinion fast instead of a paperwork ordeal.
- — A second opinion is easier to ask for once you know how to manage the relationship with your original doctor — they won't be offended.
Second Opinions for Major Diagnoses
Medicare Part B and most commercial insurers cover second opinions at the same coinsurance rate as the first opinion. Out-of-pocket cost for an uninsured virtual consult typically runs $40–$500. Roman 2025 found average $15,015 downstream cost savings in oncology — net cost to the system is negative.
Requesting records, booking the consult, ensuring records arrive ahead of the appointment, and attending — roughly 3–6 hours of administrative effort plus the consult itself. Telemedicine has collapsed the travel barrier. Emotional effort of going through the diagnosis a second time is real but typically modest.
Multiple independent cohort series (Mayo 2017, Newman 2006, Garcia 2018, Middleton 2014, Lipitz-Snyderman 2023) converge on 20–60% rates of meaningful change, and a Mayo Clinic Proceedings systematic review confirms the range (Payne 2014). National Academies 2015 frames diagnostic error as a public-health imperative. No large RCT exists — that's the only thing keeping this from a 5.
Across cancer second-opinion series, clinically meaningful management changes occur in 23–57% of cases with expected morbidity improvements in essentially all of them (Lipitz-Snyderman 2023). For the conditional population — a reader facing a major diagnosis — the felt functional improvement within weeks is clear: right treatment instead of wrong, or de-escalated treatment instead of unnecessarily aggressive.
Conditional on major diagnosis (cancer, complex surgery, life-altering medication), correcting diagnostic error or optimising treatment carries meaningful mortality stakes. Newman-Toker 2024 estimates ~795,000 annual US harms from diagnostic error; second opinions are a partial structural fix. Not a 4 because the effect is conditional on the original recommendation being wrong, and the modal reader without a major diagnosis sees little longevity gain.
Patient series consistently report greater treatment confidence after a second opinion (~53% in oncology), lower decision regret at 6 months, and better adherence to whatever plan ends up chosen (Payne 2014). The mood benefit is robust even when the second opinion confirms the first — confirmation relieves the cognitive load of 'did I do enough.'